title: Diffusion-weighted MR imaging and MGMT methylation status in glioblastoma: a reappraisal of the role of preoperative quantitative ADC measurements.
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.forename: A
authors.initials: A
authors.lastname: Prager
authors.forename: R J
authors.initials: RJ
authors.lastname: Young
authors.forename: W
authors.initials: W
authors.lastname: Shi
authors.forename: A M P
authors.initials: AM
authors.lastname: Omuro
authors.forename: J J
authors.initials: JJ
authors.lastname: Graber
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*; D038524:Diffusion Magnetic Resonance Imaging / Q000706:statistics & numerical data*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*
chemical_list: D000911:Antibodies, Monoclonal